Sunday, August 18, 2019

The EMEA investigates link between swine flu vaccine Pandemrix and narcolepsy

The European Medicines Agency is investigating a possible link between the swine flu vaccine Pandemrix and cases of narcolepsy. The review comes after a limited...

Research states that antivirals are safe for women in the first trimester of pregnancy

A study published in the Journal of the American Medical Association claims that antivirals are safe to prescribe to women in the first trimester...

A third of patients fail to get tested for chlamydia because they are too...

The National Pharmacy Association has found that around one in three patients do not get tested for chlamydia because they are too embarrassed. The survey...

Community pharmacists have role to play in battling diabetes, according to Scottish government

The Scottish government's Diabetes Action Plan 2010 has stated that community pharmacists in the country have a key role to play in supporting people...

CPPE to run 30 pharmacy workshops focusing on IT and internet skills

The Centre for Pharmacy Postgraduate Education has announced it is running 30 workshops to help pharmacists with their basic internet and IT skills. A CPPE...

UK medicines legislation brought together in MHRA document

All UK medicines legislation has been brought together in a single draft document published by the Medicines and Healthcare products Regulatory Agency. The 231-page document...

NICE warning over heart disease detection

The National Institute for health and Clinical Excellence has said that patients with heart disease or epilepsy may be missed because spontaneous blackouts are...

Bayer cautious over anti-clotting drug Xarelto

The head of cardiovascular drug development at Bayer believes that the latest data on the company's key anti-clotting drug Xarelto is "very encouraging" but...

British firm agrees $16.6m acquisition of anti-poison drugs rights

British pharmaceutical firm BTG has agreed to pay Nycomed US up to $16.6 million for the U.S. rights to market its anti-poison drugs CroFab...